We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.05B
AUM Growth
+$527M
(+21%)
Cap. Flow
+$482M
Cap. Flow
% of AUM
15.81%
Top 10 Holdings %
Top 10 Hldgs %
28.17%
Holding
230
New
83
Increased
48
Reduced
47
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$73.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.4M |
| 3 |
Amazon
AMZN
|
+$65.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$61.2M |
| 5 |
Mastercard
MA
|
+$61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$65M |
| 2 |
PayPal
PYPL
|
+$52M |
| 3 |
eBay
EBAY
|
+$48.4M |
| 4 |
NXP Semiconductors
NXPI
|
+$42.9M |
| 5 |
Qorvo
QRVO
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.94% |
| 2 | Technology | 31.58% |
| 3 | Communication Services | 6.58% |
| 4 | Consumer Discretionary | 4.22% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Quest Diagnostics
DGX
$25.8B
| $16.3M | 0.53% |
142,339
-51,505
| -27% | -$6.09M |
|
52
Merck
MRK
$316B
| $16.1M | 0.53% |
+203,456
| New | +$15.9M |
|
53
Advanced Micro Devices
AMD
$846B
| $15.9M | 0.52% |
+193,514
| New | +$14.4M |
|
54
Euronet Worldwide
EEFT
$2.8B
| $15.8M | 0.52% |
+173,432
| New | +$16.9M |
|
55
TD Synnex
SNX
$20.3B
| $15.4M | 0.51% |
+220,128
| New | +$13.8M |
|
56
Teleflex
TFX
$6.18B
| $15.3M | 0.5% |
44,820
+11,484
| +34% | +$4.25M |
|
57
Allogene Therapeutics
ALLO
$635M
| $15.1M | 0.49% |
400,233
+271,605
| +211% | +$10.2M |
|
58
Relay Therapeutics
RLAY
$4.26B
| $15M | 0.49% |
+351,823
| New | +$13.4M |
|
59
Molina Healthcare
MOH
$10.2B
| $14.7M | 0.48% |
+80,281
| New | +$14.6M |
|
|
AMED
60
DELISTED
Amedisys
AMED
| $14.1M | 0.46% |
+59,504
| New | +$13.5M |
|
61
Diodes
DIOD
$4.06B
| $14M | 0.46% |
248,201
-9,098
| -4% | -$461K |
|
62
Baidu
BIDU
$38.2B
| $13.9M | 0.45% |
109,546
-22,092
| -17% | -$2.74M |
|
63
Spotify
SPOT
$98.3B
| $13.8M | 0.45% |
+57,048
| New | +$14.7M |
|
64
Cue Biopharma
CUE
$113M
| $13.8M | 0.45% |
30,489
+8,509
| +39% | +$4.9M |
|
65
Akebia Therapeutics
AKBA
$351M
| $13.7M | 0.45% |
5,458,936
+4,814,707
| +747% | +$42.3M |
|
66
PTC Therapeutics
PTCT
$5.68B
| $13.7M | 0.45% |
292,610
+110,900
| +61% | +$5.46M |
|
67
Cooper Companies
COO
$14.5B
| $13.6M | 0.45% |
161,572
-154,024
| -49% | -$11.8M |
|
68
Acadia Pharmaceuticals
ACAD
$4.39B
| $13.5M | 0.44% |
327,415
+265,840
| +432% | +$11.5M |
|
|
RTP.U
69
DELISTED
Reinvent Technology Partners Units, each consisting of one Class A ordinary share and one-fourth of
RTP.U
| $13.2M | 0.43% |
+1,150,000
| New | +$13.2M |
|
70
Dentsply Sirona
XRAY
$2.83B
| $13M | 0.43% |
297,979
+186,042
| +166% | +$8.23M |
|
71
Cencora
COR
$60B
| $12.9M | 0.42% |
132,828
+123,998
| +1,404% | +$12.3M |
|
|
DMYD.U
72
DELISTED
dMY Technology Group, Inc. II Units, each consisting of one share of Class A common stock and one-th
DMYD.U
| $12.7M | 0.42% |
+1,240,000
| New | +$12.6M |
|
73
Fox Class A
FOXA
$24.6B
| $12.5M | 0.41% |
+448,393
| New | +$11.9M |
|
74
Cardinal Health
CAH
$55.2B
| $12.3M | 0.4% |
+262,967
| New | +$13.5M |
|
75
iShares Russell 2000 ETF
IWM
$83B
| $12.2M | 0.4% |
+81,218
| New | +$12.2M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Woodline Partners held 230 positions worth $3.05B, up 21% from $2.52B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Woodline Partners deployed $482M of net new capital in Q3 2020, opening 83 new positions and adding to 48 existing holdings. Its largest new stake was Microchip Technology: 1,413,308 shares worth $72.6M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Intel, an estimated $65M trimmed.
- Woodline Partners's largest Q3 2020 buy was Microchip Technology: 1,413,308 shares worth $72.6M.
- Woodline Partners added most to Johnson & Johnson in Q3 2020, an estimated $61.2M increase.
- Woodline Partners's biggest Q3 2020 reduction was Intel, cutting an estimated $65M.
- Woodline Partners fully exited PayPal in Q3 2020, selling an estimated $52M.
- Woodline Partners's ten largest holdings make up 28% of its $3.05B portfolio in Q3 2020.
- Woodline Partners opened 83 new positions and closed 52 in Q3 2020.
- Woodline Partners's portfolio value rose 21% quarter-over-quarter to $3.05B.
Based on Woodline Partners's 13F filing for Q3 2020, filed 16 Nov 2020.